Equity Insights April 5th: Apple Inc, Cooper, SanDisk, Medicis Pharma, AngioDynamics
Apple Inc. (NASDAQ:AAPL): Jefferies raised its 2013 earnings estimate for Apple to $53.98 from $49.20, above the consensus estimate of $49.38, citing increased confidence in the iTV launch. Jefferies expects Apple to sell 2M televisions in Q4 and 10M in 2013. The firm upped its price target for shares to $800 and reiterates a Buy rating on Apple.
The Cooper Companies Inc. (NYSE:COO): After meeting with management, William Blair said it views Cooper Companies as its top pick among all the companies it covers. The firm finds shares of Cooper are highly compelling at current levels and recommends investors build or add to positions.
SanDisk Corp. (NASDAQ:SNDK): Bernstein believes the NAND industry has favorable dynamics and that SanDisk will be a 2H 2012 and 2013 story driven by the smartphone product cycle, SSDs in ultrabooks, enterprise storage, and seasonality. Shares are Outperform rated with a $75 price target.
Medicis Pharmaceutical Corp. (NYSE:MRX): Medicis added to the short-term buy list at Deutsche Bank
AngioDynamics Inc. (NASDAQ:ANGO): Canaccord believes AngioDynamics risk/reward is favorable given ongoing NanoKnife clinical trials, recovering from product recalls, and increased spending on its quality control program. Shares are Buy rated with a $16.50 price target.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.